• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Johnson & Johnson to settle DePuy ASR claims for $4B

Report: Johnson & Johnson to settle DePuy ASR claims for $4B

November 13, 2013 By Brad Perriello

Report: Johnson & Johnson to settle DePuy ASR claims for $4B

Johnson & Johnson (NYSE:JNJ) is said to be close to settling the thousands of pending and future lawsuits involving its recalled DePuy ASR metal-on-metal hip implants, according to Bloomberg.

The settlement, which would allow ASR patients whose implants have not yet failed to join the agreement, is worth about $4 billion, Bloomberg reported. That works out to an average of $300,000 to $350,000 per plaintiff, according to the news service.

It would be the largest product liability settlement in history by a wide margin if it goes through, eclipsing Swiss medical device maker Sulzer Medica’s $1 billion settlement of lawsuits involving its recalled hip implant in 2002. That recall involved roughly 31,000 devices, compared with the recall of about 93,000 DePuy ASR implants.

Citing "3 people familiar with the deal," Bloomberg reported that the agreement would put to rest some 7,500 of the estimated 12,000 lawsuits filed in state and federal courts over the DePuy ASR device, which Johnson & Johnson pulled in 2010 after receiving reports that a higher-than-normal number of patients required surgeries to correct or remove defective implants.

Johnson & Johnson has already dropped $993 million on medical costs and informing patients and surgeons about the recall, a DePuy spokeswoman told the news service. The settlement could wind up costing more than $4 billion because it allows patients whose DePuy ASR implants fail in the future to seek compensation, the anonymous sources said. The deal’s provisions require at least 94% of eligible claimants to sign on or J&J can back out, they said.

In October, J&J settled 1 lawsuit filed over the hip implant, a month after a federal judge delayed for a 2nd time the 1st bellwether trial in the multidistrict litigation over the DePuy ASR implant (other cases are proceeding outside of the MDL). The 1st trial over the DePuy ASR implant settled in August 2012 before it could go to trial. In March, a jury awarded another plaintiff, Loren Kransky, $8.3 million after deciding that the device was defectively designed (California Judge J. Stephen Czuleger rejected DePuy’s request for a new trial in May). In April, an Illinois state jury found for DePuy in Carol Strum vs. DePuy Orthopaedics & Premier Orthopaedic Sales.

Filed Under: Implants, Legal News, News Well, Product Liability, Recalls Tagged With: depuysynthes, Hips, Johnson and Johnson

More recent news

  • Real-world data backs Route 92 reperfusion system
  • LivsMed unveils new surgical robot with telesurgery capabilities
  • JenaValve enrolls first patient in TAVR for AR study
  • HistoSonics expands insurance coverage for histotripsy treatment
  • Johnson & Johnson MedTech gets updated FDA nod for Varipulse PFA

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy